ウェアラブル医療機器の世界市場-2024～2031年

ウェアラブル医療機器の世界市場は、2023年に357億米ドルに達し、2024年から2031年にかけてCAGR 24.6%で成長し、2031年には2,074億7,000万米ドルに達すると予測されています。

ウェアラブル医療機器はヘルスケア技術における重要な進歩であり、健康指標をリアルタイムでモニターするように設計されています。これらのデバイスは、フィットネストラッカーからECGパッチのような特殊なモニターに至るまで、貴重な健康に関する洞察を提供し、特にサービスが行き届いていない地域での遠隔患者モニタリングを容易にします。収集されたデータはヘルスケアプロバイダーに直接送信され、臨床上の意思決定を強化し、患者の転帰を改善する可能性があります。しかし、ウェアラブル医療機器の急速な普及は、ユーザー受容性、セキュリティ、倫理的意味合いに関する懸念を引き起こしています。現代のヘルスケアシステムにおいてウェアラブル医療機器の可能性を完全に実現するためには、これらの問題に対処することが極めて重要です。同市場は大きな収益を上げると予測されています。

市場力学：

促進要因と阻害要因

慢性疾患の蔓延と健康意識の高まり

世界中で使用されているウェアラブル医療機器は、多くの要因によって需要が増加し、非常に繁栄しています。その1つは、糖尿病、心血管疾患、呼吸器疾患などのような慢性疾患の絶え間ない蔓延であり、継続的なモニタリングとプロアクティブマネージメントが必要です。例えるなら、糖尿病患者のためのグルコースモニタリングデバイス、心臓血管の健康のための心拍数モニター、これらは定番になりつつあります。また、消費者の健康意識の高まりも、予防医療へのウェアラブル技術の採用を後押ししています。

世界中の政府やヘルスケア機関は、病院への再入院を減らし、患者の転帰を向上させるために、これらの機器を提唱しています。また、リアルタイムのデータ追跡、分析、警告のためのデジタルヘルスプラットフォームやモバイルアプリとの連携も魅力的です。

例えば、米国疾病予防管理センターによると、米国には心臓病、がん、糖尿病、肥満、高血圧など、少なくとも1つの主要な慢性疾患を持つ人が1億2,900万人います。米国の主要死因トップ10のうち5つが、予防・治療可能な慢性疾患に関連しています。過去20年間、有病率は着実に増加しており、この傾向は今後も続くと予想されます。複数の慢性疾患を抱えるアメリカ人の割合は増加しており、42％が2つ以上、12％が少なくとも5つの慢性疾患を抱えています。慢性疾患は米国のヘルスケアシステムにも大きな影響を与えており、年間4兆1,000億米ドルの支出の90％を占めています。

グルコースモニター、スマートウォッチ、フィットネストラッカーなどのこれらのデバイスは、患者やヘルスケアプロバイダーがこれらの状態を効果的に管理するのに役立っています。慢性疾患の経済的負担は年間ヘルスケア支出の90%を占め、費用対効果の高いソリューションの必要性を強調しています。慢性疾患の有病率の上昇と多機能ウェアラブルのニーズが、世界の進歩と市場拡大の原動力となっています。

データのプライバシーとセキュリティへの懸念

ウェアラブル医療機器市場は、データプライバシーとセキュリティの懸念による課題に直面しています。膨大な量の機密健康データが生成・送信されるため、不正アクセス、データ漏洩、個人健康情報の悪用に対する懸念が生じています。特にデバイスがIoTを通じて相互接続されるようになると、サイバーセキュリティの脅威がユーザーの信頼に対する課題となります。地域間で標準化された規制がないことが、状況をさらに複雑にしています。消費者はプライバシーへの懸念からこうした技術の採用をためらっており、市場の成長を鈍らせる可能性があります。企業は、堅牢なセキュリティプロトコルに投資し、進化する法的枠組みを遵守する必要に迫られています。

目次

第1章 調査手法と調査範囲

第2章 定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

• 影響要因
  • 促進要因
    • 慢性疾患の増加と健康意識
• 抑制要因
  • データのプライバシーとセキュリティに関する懸念
• 機会
  • 影響分析

第5章 産業分析

• ポーターのファイブフォース分析
• サプライチェーン分析
• 価格分析
• 規制分析

第6章 製品タイプ別

• 診断およびモニタリング機器
• 治療機器

第7章 用途別

• 遠隔患者モニタリング
• スポーツとフィットネスのモニタリング
• 慢性疾患管理
• その他

第8章 エンドユーザー別

• 病院・クリニック
• ホームケア設定
• 外来診療センター
• フィットネスセンターとスポーツ施設

第9章 地域別

• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • フランス
  • スペイン
  • イタリア
  • その他欧州地域
• 南米
  • ブラジル
  • アルゼンチン
  • その他南米
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• 中東・アフリカ

第10章 競合情勢

• 競合シナリオ
• 市況・シェア分析
• M&A分析

第11章 企業プロファイル

• Koninklijke Philips N.V
  • 会社概要
  • 製品ポートフォリオと概要
  • 財務概要
  • 主な発展
• Garmin Ltd
• Medtronic
• Omron
• Withings
• VitalConnect
• Polar Electro
• Sotera, Inc
• INVIZA Corporation
• GE HealthCare

第12章 付録

The global wearable medical devices market reached US$ 35.7 billion in 2023 and is expected to reach US$ 207.47 billion by 2031, growing at a CAGR of 24.6% during the forecast period 2024-2031.

Wearable medical devices are a significant advancement in healthcare technology, designed to monitor health metrics in real-time. These devices, ranging from fitness trackers to specialized monitors like ECG patches, provide valuable health insights and facilitate remote patient monitoring, especially in underserved areas. The data collected can be transmitted directly to healthcare providers, enhancing clinical decision-making and potentially improving patient outcomes. However, the rapid adoption of wearable medical devices raises concerns about user acceptance, security, and ethical implications. Addressing these issues is crucial for the full realization of their potential in modern healthcare systems. The market is projected to generate substantial revenue.

Market Dynamics: Drivers & Restraints

Growing Prevalence of Chronic Diseases and Health Awareness

Wearable medical devices used all over the world are highly prospering as their demand increases because of many factors; one of them is the incessantly growing prevalence of chronic diseases like diabetes, cardiovascular diseases, respiratory conditions, etc., which requires continuous monitoring and proactive management where wearable devices quite easily can cater to the need. To illustrate, glucose monitoring devices for diabetic patients, heart rate monitors for cardiovascular health; these are becoming staples. Also, increased health consciousness among consumers further induces the adoption of wearable technologies for preventive care.

Governments and healthcare organizations all over the world are advocating about these devices to reduce readmissions into hospitals and enhance patient outcomes. They also become more attractive with their association with digital health platforms and mobile applications for real-time data tracking, analysis, and alert.

For instance, according to Centers for Disease Control and Prevention, the US has 129 million people with at least one major chronic disease, including heart disease, cancer, diabetes, obesity, and hypertension. Five of the top 10 leading causes of death in the US are associated with preventable and treatable chronic diseases. Over the past two decades, prevalence has steadily increased, and this trend is expected to continue. An increasing proportion of Americans are dealing with multiple chronic conditions, with 42% having two or more and 12% having at least five. Chronic diseases also significantly impact the US healthcare system, accounting for 90% of annual $4.1 trillion expenditure.

These devices, such as glucose monitors, smartwatches, and fitness trackers, help patients and healthcare providers manage these conditions effectively. The financial burden of chronic diseases, accounting for 90% of annual healthcare expenditure, underscores the need for cost-effective solutions. The rising prevalence of chronic diseases and the need for multifunctional wearables drive advancements and market expansion worldwide.

Data Privacy and Security Concerns

The wearable medical device market faces challenges due to data privacy and security concerns. With the vast amount of sensitive health data generated and transmitted, concerns about unauthorized access, data breaches, and misuse of personal health information arise. Cybersecurity threats, particularly as devices become interconnected through IoT, pose a challenge to user trust. The lack of standardized regulations across regions further complicates the situation. Consumers are hesitant to adopt these technologies due to privacy concerns, potentially slowing market growth. Companies face increasing pressure to invest in robust security protocols and comply with evolving legal frameworks.

Segment Analysis

The global wearable medical devices market is segmented based on product type, application, end user and region.

Product type:

Diagnostic & Monitoring Devices segment is expected to dominate the wearable medical devices market share

The diagnostic & monitoring devices segment holds a major portion of the wearable medical devices market share and is expected to continue to hold a significant portion of the wearable medical devices market share during the forecast period.

The Global Wearable Medical Devices Market is certainly buoyed up and influencing the expansion and adoption of the various diagnostic and monitoring devices that feature prominently in it. Such devices are crafted, as the ultimate end purpose, for the real-time physiological and biometric data gathering to allow a continuous monitoring and early diagnosis of different health conditions.

Examples of such products include continuous glucose monitoring systems, ECG monitoring systems, pulse oximeters, and blood pressure monitoring systems. These systems are basically used for the management of most chronic conditions such as diabetes, cardiovascular diseases, and respiratory diseases. They enable the patients to keep a convenient and informative record of their own health metrics.

For instance, in October 2024, Samsung has launched the Galaxy Ring in India, a wearable device designed to enhance digital health through Galaxy AI. The sleek and compact device offers personalized health insights and tailored experiences. The Galaxy Ring is a significant step in active and autonomous health management, providing users with valuable guidance for healthier lifestyles. Its advanced sensors provide insights into users' lifestyle patterns, helping them manage their health goals.

Moreover, in June 2024, Elemind, a neurotech wellness company, has introduced a unique neurotechnology headband that enhances sleep performance by directing brainwaves out of wakeful patterns. The wearable device reduced the time to sleep in 76% of study participants by 48% and up to 74%.

Moreover, these enable healthcare providers to carry out the needed remoting of their patients leading to timely interventions and positive health outcomes. Advanced sensor-integrated, AI-driven analytics crammed in these devices will enhance the parameters while boosting their accuracy and predictive capability to provide actionable insight as well.

Application:

Remote Patient Monitoring segment is the fastest-growing segment in wearable medical devices market share

The remote patient monitoring segment is the fastest-growing segment in the wearable medical devices market share and is expected to hold the market share over the forecast period.

Remote Patient Monitoring is a fast-growing aspect of the global wearable medical devices market which needs lots of solutions regarding continuous work with healthcare access and management in places other than clinical environments. remote patient monitoring devices include wearable ECG monitors, glucose trackers, and respiratory sensors. It used to enable providers to monitor their patients' vital signs and chronic conditions in real time from anywhere. It mostly benefits elderly people, those whose mobility is challenged, and those suffering from chronic diseases that require frequent measurement by health care professionals. remote patient monitoring is a great growth opportunity for hospital readmissions, encourages patient engagement with the system, and provides early intervention in the event of abnormalities, which collectively improves health outcomes.

Moreover, rapid advancement of technologies such as telehealth applications and healthcare digitalization, along with the growing need for cost-effective solutions to reduce the burden on the healthcare systems, have significantly increased uptake of remote patient monitoring. this change in the trend will create a significant shift toward value-based care and make remote patient monitoring a critical and essential component of the growth seen in the global market for wearable medical devices.

Geographical Analysis

North America is expected to hold a significant position in the wearable medical devices market share

North America holds a substantial position in the wearable medical devices market and is expected to hold most of the market share.

North America is one of the prominent regions in the Global Wearable Medical Devices Market, and the following are the prime drivers for this. Chronic diseases such as diabetes, cardiovascular diseases, and obesity are prevalent in the region, giving rise to a considerable demand for such technologies where monitoring and management can be performed in real time. Rapid growth is also due to the higher adoption of digital health solutions and improved healthcare infrastructure. The high disposable income, along with the readiness of consumers to adopt advanced medical technologies, further push the use of such devices. Government initiatives to promote preventive healthcare and telemedicine encourage adoption as well.

For instance, in November 2024, Aktiia has launched its continuous blood pressure monitoring bracelet in Canada, marking its first market expansion outside Europe. The company's CEO, Raghav Gupta, praised Canada's collaborative healthcare environment for its ideal position to integrate innovative products. The launch aims to make it easier for millions of people to monitor their cardiovascular health, with smooth pathways for product adoption, clinical trials, and partnerships with healthcare providers across the country.

Europe is growing at the fastest pace in the wearable medical devices market

Europe holds the fastest pace in the wearable medical devices market and is expected to hold most of the market share due to the rise in chronic diseases like diabetes, cardiovascular conditions, and obesity, necessitating continuous health monitoring. The region's established healthcare infrastructure and high healthcare expenditure enable advanced wearable technologies adoption. The growing aging population and awareness of preventive healthcare support market growth. Favourable regulatory frameworks and increased investment in research contribute to innovation. Smartphone penetration and wireless connectivity have made it easier for patients and healthcare professionals to integrate wearable devices into their routines.

For instance, in June 2023, Lithuanian high-tech company Teltonika has launched TeltoHeart, a multifunctional smart medical wristband designed to help people with heart rhythm problems. The device, created by Arvydas Paukstys, was inspired by a highly accurate algorithm developed by Kaunas University of Technology and Vilnius University. Teltonika agreed to license this unique and patented technology, marking the beginning of a long road to developing a global gadget with exceptional technical capabilities.

Competitive Landscape

The major global players in the wearable medical devices market include Koninklijke Philips N.V.; Fitbit (Google); Garmin Ltd.; Medtronic; Omron; Withings; VitalConnect; Polar Electro; Sotera, Inc.; INVIZA Corporation; Dexcom, Inc.; GE HealthCare; CONTEC MEDICAL SYSTEMS CO., LTD; Nanowear Inc. among others.

Emerging Players

The emerging players in the wearable medical devices market include Nuubo, Activinsights Ltd, Intelesens Ltd , Polar Electro Oy and among others

Key Developments

• In January 2024, Fitbit and Quest Diagnostics have partnered to study the use of wearable devices to improve metabolic health, which affects the risk of developing diseases like diabetes and heart disease. The Wearables for Metabolic Health (WEAR-ME) pilot study will combine behavioral and biometric data from Fitbit devices with Quest Diagnostics' laboratory tests to enhance metabolic health assessment and management, aiding disease prevention.
• In April 2023, Garmin Ltd. has extended regional availability of its Dexcom Connect IQ apps, specifically designed for Type 1 or Type 2 diabetes users. These apps allow users to monitor glucose levels and trends on compatible smartwatches or cycling computers. The announcement is expected to impact the wearable medical devices market, enhancing accessibility to glucose monitoring solutions.

Why Purchase the Report?

• Pipeline & Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
• Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
• Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
• Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
• Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
• Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
• Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
• Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
• Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
• Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
• Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
• Post-market Surveillance: Uses post-market data to enhance product safety and access.
• Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global wearable medical devices market report delivers a detailed analysis with 60+ key tables, more than 50 visually impactful figures, and 176 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2023

• Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
• Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
• Component & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
• Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
• Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
• Supply Chain: Distribution and Supply Chain Managers.
• Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
• Academic & Research: Academic Institutions.

Table of Contents

1. Methodology and Scope

• 1.1. Research Methodology
• 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

• 3.1. Snippet by Product Type
• 3.2. Snippet by Application
• 3.3. Snippet by End User
• 3.4. Snippet by Region

4. Dynamics

• 4.1. Impacting Factors
  • 4.1.1. Drivers
    • 4.1.1.1. Growing Prevalence of Chronic Diseases and Health Awareness
• 4.2. Restraints
  • 4.2.1.1. Data Privacy and Security Concerns
• 4.3. Opportunity
  • 4.3.1. Impact Analysis

5. Industry Analysis

• 5.1. Porter's Five Force Analysis
• 5.2. Supply Chain Analysis
• 5.3. Pricing Analysis
• 5.4. Regulatory Analysis

6. By Product type

• 6.1. Introduction
  • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product type
  • 6.1.2. Market Attractiveness Index, By Product type
• 6.2. Diagnostic & Monitoring Devices*
  • 6.2.1. Introduction
  • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 6.3. Therapeutic Devices

7. By Application

• 7.1. Introduction
  • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 7.1.2. Market Attractiveness Index, By Application
• 7.2. Remote Patient Monitoring*
  • 7.2.1. Introduction
  • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 7.3. Sports and Fitness Monitoring
• 7.4. Chronic Disease Management
• 7.5. Others

8. By End User

• 8.1. Introduction
  • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 8.1.2. Market Attractiveness Index, By End User
• 8.2. Hospitals & Clinics*
  • 8.2.1. Introduction
  • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 8.3. Homecare Settings
• 8.4. Ambulatory Care Centers
• 8.5. Fitness Centers and Sports Institutes

9. By Region

• 9.1. Introduction
  • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
  • 9.1.2. Market Attractiveness Index, By Region
• 9.2. North America
  • 9.2.1. Introduction
  • 9.2.2. Key Region-Specific Dynamics
  • 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 9.2.6.1. U.S.
    • 9.2.6.2. Canada
    • 9.2.6.3. Mexico
• 9.3. Europe
  • 9.3.1. Introduction
  • 9.3.2. Key Region-Specific Dynamics
  • 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 9.3.6.1. Germany
    • 9.3.6.2. U.K.
    • 9.3.6.3. France
    • 9.3.6.4. Spain
    • 9.3.6.5. Italy
    • 9.3.6.6. Rest of Europe
• 9.4. South America
  • 9.4.1. Introduction
  • 9.4.2. Key Region-Specific Dynamics
  • 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 9.4.6.1. Brazil
    • 9.4.6.2. Argentina
    • 9.4.6.3. Rest of South America
• 9.5. Asia-Pacific
  • 9.5.1. Introduction
  • 9.5.2. Key Region-Specific Dynamics
  • 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 9.5.6.1. China
    • 9.5.6.2. India
    • 9.5.6.3. Japan
    • 9.5.6.4. South Korea
    • 9.5.6.5. Rest of Asia-Pacific
• 9.6. Middle East and Africa
  • 9.6.1. Introduction
  • 9.6.2. Key Region-Specific Dynamics
  • 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

10. Competitive Landscape

• 10.1. Competitive Scenario
• 10.2. Market Positioning/Share Analysis
• 10.3. Mergers and Acquisitions Analysis

11. Company Profiles

• 11.1. Koninklijke Philips N.V*
  • 11.1.1. Company Overview
  • 11.1.2. Product Portfolio and Description
  • 11.1.3. Financial Overview
  • 11.1.4. Key Developments
• 11.2. Garmin Ltd
• 11.3. Medtronic
• 11.4. Omron
• 11.5. Withings
• 11.6. VitalConnect
• 11.7. Polar Electro
• 11.8. Sotera, Inc
• 11.9. INVIZA Corporation
• 11.10. GE HealthCare

LIST NOT EXHAUSTIVE

12. Appendix

• 12.1 About Us and Services
• 12.2 Contact Us